Vimarsana
Biggest News Aggregation in the World

Multiple Cause News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Multiple Cause. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Multiple Cause Today - Breaking & Trending Today

Amarin Applauds HealthyWomen's Citizen's Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event - Vimarsana News

Amarin Applauds HealthyWomen's Citizen's Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event

Citizen Petition Spotlights Risks for Patients on Drug Proven to Have No Benefit in Improving Cardiovascular Outcomes and Need for Urgent Regulatory Action to Protect PatientsDUBLIN, Ireland and...

Uncovering the real story behind opioid prescriptions and deaths - Vimarsana News

Uncovering the real story behind opioid prescriptions and deaths

As a patient advocate and health care writer, I'm reminded of the saying "Figures don't lie, but liars figure," and it applies to the CDC's misrepresentation of opioid-related data, which indicates no direct link between clinical opioid prescribing and mortality.

Steady Rise in CVD Deaths Linked to Substance Abuse, US Data Show - Vimarsana News

Steady Rise in CVD Deaths Linked to Substance Abuse, US Data Show

No demographic was immune to CV deaths tied to alcohol, opioids, and other drugs over the last two decades.

Source: tctmd.com
Peripartum Drug Overdose Deaths Increased During COVID-19 - Vimarsana News

Peripartum Drug Overdose Deaths Increased During COVID-19

Drug overdose deaths during the peripartum period more than tripled among women aged 35 to 44 years during the COVID-19 pandemic.

Peripartum Drug Overdose Deaths Increased During COVID-19 - Vimarsana News

Peripartum Drug Overdose Deaths Increased During COVID-19

Drug overdose deaths during the peripartum period more than tripled among women aged 35 to 44 years during the COVID-19 pandemic.